v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 48,665 $ 29,809 $ 90,149 $ 53,166
General and administrative 26,412 11,094 44,148 19,896
Total operating expenses 75,077 40,903 134,297 73,062
Loss from operations (75,077) (40,903) (134,297) (73,062)
Other income/(expense):        
Interest income 3,587 2,774 7,044 5,207
Interest expense (1,233) (2,338) (2,478) (2,940)
Foreign exchange loss, net (32) (49) (76) (68)
Change in fair value of 2022 USD Financing Warrants (86,231) (2,228) (106,277) 4,771
Total other income/(expense) (83,909) (1,841) (101,787) 6,970
Net loss (158,986) (42,744) (236,084) (66,092)
Other comprehensive loss        
Unrealized gain/(loss) on investments (406) 36 (668) 46
Loss on foreign currency translation (1) (31) 0 (58)
Comprehensive loss $ (159,393) $ (42,739) $ (236,752) $ (66,104)
Net loss per common share, basic $ (1.44) $ (0.5) $ (2.15) $ (0.78)
Net loss per common share, diluted $ (1.44) $ (0.5) $ (2.15) $ (0.81)
Weighted-average common shares, basic 110,684,720 85,347,677 109,743,062 85,208,539
Weighted-average common shares, diluted 110,684,720 85,347,677 109,743,062 87,099,006